Rocket Pharmaceuticals, Inc. (RCKT) NASDAQ

3.27

-0.0107(-0.33%)

Updated at September 08 03:02PM

Currency In USD

Rocket Pharmaceuticals, Inc.

Address

9 Cedarbrook Drive

Cranbury, NJ 08512

United States of America

Phone

609 659 8001

Sector

Healthcare

Industry

Biotechnology

Employees

299

First IPO Date

February 18, 2015

Key Executives

NameTitlePayYear Born
Dr. Gaurav D. Shah M.D.Chief Executive Officer & Director841,4341975
Mr. Aaron OndreyChief Financial Officer598,9531977
Mr. Martin Louis Wilson J.D.General Counsel, Chief Compliance Officer & Chief Corporate Officer613,9791976
Dr. Jonathan Schwartz M.D.Chief Medical & Gene Therapy Officer614,3341964
Mr. Raj Prabhakar M.B.A.Chief Business Officer619,1271974
Dr. Kinnari Patel M.B.A., Pharm.D.Head of R&D, President & Chief Operating Officer696,0901979
Kevin GiordanoDirector of Corporate Communications0N/A
Ms. Sarbani Chaudhuri M.B.A.Chief Commercial & Medical Affairs Officer01975
Dr. Gayatri R. Rao J.D., M.D.Senior Vice President of Clinical Safety & Chief Regulatory Officer0N/A
Ms. Isabel Carmona J.D.Chief People Officer0N/A

Description

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; CIEMAT and UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey.